Baird served as a co-manager on this offering
AboutEvolent Health, Inc. (“Evolent” or the “Company”) (NYSE:EVH) recently completed a follow-on offering of 8,816,120 common shares at a price of $19.85 per share, generating gross proceeds of approximately $175 million. Evolent has granted to the underwriters of the offering a 30-day option to purchase up to an additional 1,322,418 shares of common stock. The Company intends to use the net proceeds of this offering for working capital and general corporate purposes, including to expand its business through acquisitions and investments.
Evolent partners with leading healthcare provider organizations to achieve superior clinical and financial results in value-based care. With a provider heritage and over 20 years of health plan administration experience, the Company operates in more than 30 United States healthcare markets, actively managing care across Medicare, Medicaid, commercial and self-funded adult and pediatric populations. Evolent is headquartered in Arlington, Virginia.
CONTACT US TO LEARN MORE
- August 2017
- Evolent Health, Inc.
- Target Location
- North America